Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DIAZEPAM BASI 5 MG/ML SOLUCIÓN INYECTABLE EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/DIAZEPAM BASI 5 MG/ML SOLUCIÓN INYECTABLE EFG

Approved

STANDARD

DIAZEPAM BASI 5 MG/ML SOLUCIÓN INYECTABLE EFG

Laboratorios Basi Industria Farmaceutica S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 13, 2024
Approval ID: 953503ae519b6bc3
Company: Laboratorios Basi Industria Farmaceutica S.A.
Type: Standard

Approval Details

Approval Id: 953503ae519b6bc3
Drug Cima Aemps Name: DIAZEPAM BASI 5 MG/ML SOLUCIÓN INYECTABLE EFG
Register Number: 89559
Holder Company Name: Laboratorios Basi Industria Farmaceutica S.A.
Marketing Company Name: Laphysan S.A.U.
Authorization Date: 2024-05-13
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 5 mg/ml
Route Of Administration: VÍA INTRAMUSCULAR, VÍA INTRAVENOSA
Prescription Type: Medicamento Sujeto A Prescripción Médica. Psicótropos
Commercialized: Yes
Company Name: Laboratorios Basi Industria Farmaceutica S.A.

Active Ingredients

DIAZEPAM

10 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 13, 2024

Approval ID

953503ae519b6bc3

Type

Standard

Back to CIMA-AEMPS Approvals